Nigeria Reports 559 Infections In 15 States, Five Deaths


Nigeria Reports 559 Infections In 15 States, Five DeathsNigeria Centre for Disease Control (NCDC) confirmed 559 COVID-19 infections across 14 states and the federal capital territory (FCT) on Wednesday.

Lagos, the worst-hit state in the country, recorded 232 positive samples, representing 41.5 percent of the total cases recorded on Wednesday.

Other states that reported fresh infections include Rivers (83), Enugu (66), Oyo (28), Kaduna (25), FCT (24), Delta (22), Akwa Ibom (19), Kwara (18), Ekiti (13), Bayelsa (9), Cross River (9), Ogun (6), Kano (3) and Gombe (2).

Also, NCDC revealed that 220 patients were discharged, while five persons unfortunately died of COVID-19 complications.

The agency added that Wednesday’s report includes two deaths and six recoveries in Lagos for September 7, 2021.

Currently, Nigeria has 197,046 confirmed COVID-19 cases, 185,379 recoveries and 2,578 fatalities.

In other news, World Health Organisation (WHO) has asked manufacturers of COVID-19 vaccines and rich countries to deliver pledged doses to poor countries and stop making “excuses”.

Tedros Adhanom Ghebreyesus, director-general of WHO, said this during a media briefing on Wednesday.

He expressed;

We have heard excuses from manufacturers and some high-income countries about how low-income countries cannot absorb vaccines.

Because manufacturers have prioritised or been legally obliged to fulfil bilateral deals with rich countries willing to pay top dollar, low-income countries have been deprived of the tools to protect their people.”

Meanwhile, US Food and Drug Administration has declined the request for an emergency authorisation of lenzilumab drug to treat hospitalised COVID-19 patients.

Humanigen, the maker of lenzilumab drug, disclosed in a statement on Thursday.

The statement partly reads;

In its letter, FDA stated that it was unable to conclude that the known and potential benefits of lenzilumab outweigh the known and potential risks of its use as a treatment for COVID-19.

Leave A Reply

Your email address will not be published.